Your browser doesn't support javascript.
loading
Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
Bernard, Fanette; Uppungunduri, Chakradhara Rao S; Meyer, Stephan; Cummins, Michelle; Patrick, Katharine; James, Beki; Skinner, Roderick; Tewari, Sanjay; Carpenter, Ben; Wynn, Robert; Veys, Paul; Amrolia, Persis.
  • Bernard F; Paediatric Onco-Haematology Unit, Geneva University Hospital, Geneva, Switzerland.
  • Uppungunduri CRS; CANSEARCH research laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Meyer S; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Cummins M; Teenage and Young Adult Cancer, The Christie NHS Foundation Trust, Manchester, UK.
  • Patrick K; Department of Haematology and Oncology, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
  • James B; Department of Paediatric Haematology and Bone Marrow Transplantation, Bristol Royal Hospital for Children, Bristol, UK.
  • Skinner R; Department of Paediatric Haematology, Sheffield Children's Hospital, Sheffield, UK.
  • Tewari S; Department of Paediatric Oncology and Haematology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Carpenter B; Department of Paediatric and Adolescent Haematology and Oncology, Great North Children's Hospital, Newcastle upon Tyne, UK.
  • Wynn R; Department of Paediatric Haematology/Oncology, The Royal Marsden Hospital NHS Trust, Sutton, UK.
  • Veys P; Department of Haematology, University College London Hospitals NHS Trust, London, UK.
  • Amrolia P; Department of Blood and Marrow Transplant, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Br J Haematol ; 193(4): 804-813, 2021 05.
Article en En | MEDLINE | ID: mdl-33855694

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Acondicionamiento Pretrasplante / Ciclofosfamida / Anemia de Fanconi / Donante no Emparentado / Alemtuzumab / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Acondicionamiento Pretrasplante / Ciclofosfamida / Anemia de Fanconi / Donante no Emparentado / Alemtuzumab / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article